230 related articles for article (PubMed ID: 32681936)
1. The microbiota-gut-brain axis: An emerging therapeutic target in chemotherapy-induced cognitive impairment.
Subramaniam CB; Bowen JM; Gladman MA; Lustberg MB; Mayo SJ; Wardill HR
Neurosci Biobehav Rev; 2020 Sep; 116():470-479. PubMed ID: 32681936
[TBL] [Abstract][Full Text] [Related]
2. Neuroimmune reactivity marker expression in rodent models of chemotherapy-induced cognitive impairment: A systematic scoping review.
George RP; Semendric I; Hutchinson MR; Whittaker AL
Brain Behav Immun; 2021 May; 94():392-409. PubMed ID: 33516919
[TBL] [Abstract][Full Text] [Related]
3. Nrf2 Signaling Pathway: a Potential Therapeutic Target in Combating Oxidative Stress and Neurotoxicity in Chemotherapy-Induced Cognitive Impairment.
Lal R; Dharavath RN; Chopra K
Mol Neurobiol; 2024 Feb; 61(2):593-608. PubMed ID: 37644279
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-induced cognitive impairment (CICI): An overview of etiology and pathogenesis.
Mounier NM; Abdel-Maged AE; Wahdan SA; Gad AM; Azab SS
Life Sci; 2020 Oct; 258():118071. PubMed ID: 32673664
[TBL] [Abstract][Full Text] [Related]
5. Inflammation and gut-brain axis link obesity to cognitive dysfunction: plausible pharmacological interventions.
Solas M; Milagro FI; Ramírez MJ; Martínez JA
Curr Opin Pharmacol; 2017 Dec; 37():87-92. PubMed ID: 29107872
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Potential Role of the Gut Microbiome in Chemotherapy-Induced Neurocognitive Disorders and Cardiovascular Toxicity.
Ciernikova S; Mego M; Chovanec M
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33668518
[TBL] [Abstract][Full Text] [Related]
7. The triangle of death of neurons: Oxidative damage, mitochondrial dysfunction, and loss of choline-containing biomolecules in brains of mice treated with doxorubicin. Advanced insights into mechanisms of chemotherapy induced cognitive impairment ("chemobrain") involving TNF-α.
Ren X; Keeney JTR; Miriyala S; Noel T; Powell DK; Chaiswing L; Bondada S; St Clair DK; Butterfield DA
Free Radic Biol Med; 2019 Apr; 134():1-8. PubMed ID: 30593843
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of cytokine mediated chemotherapy induced cognitive impairment.
Ren X; St Clair DK; Butterfield DA
Pharmacol Res; 2017 Mar; 117():267-273. PubMed ID: 28063894
[TBL] [Abstract][Full Text] [Related]
9. Supplement of microbiota-accessible carbohydrates prevents neuroinflammation and cognitive decline by improving the gut microbiota-brain axis in diet-induced obese mice.
Shi H; Wang Q; Zheng M; Hao S; Lum JS; Chen X; Huang XF; Yu Y; Zheng K
J Neuroinflammation; 2020 Mar; 17(1):77. PubMed ID: 32127019
[TBL] [Abstract][Full Text] [Related]
10. An Overview on Chemotherapy-induced Cognitive Impairment and Potential Role of Antidepressants.
Das A; Ranadive N; Kinra M; Nampoothiri M; Arora D; Mudgal J
Curr Neuropharmacol; 2020; 18(9):838-851. PubMed ID: 32091339
[TBL] [Abstract][Full Text] [Related]
11. β-glucan attenuates cognitive impairment via the gut-brain axis in diet-induced obese mice.
Shi H; Yu Y; Lin D; Zheng P; Zhang P; Hu M; Wang Q; Pan W; Yang X; Hu T; Li Q; Tang R; Zhou F; Zheng K; Huang XF
Microbiome; 2020 Oct; 8(1):143. PubMed ID: 33008466
[TBL] [Abstract][Full Text] [Related]
12. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.
Kesika P; Suganthy N; Sivamaruthi BS; Chaiyasut C
Life Sci; 2021 Jan; 264():118627. PubMed ID: 33169684
[TBL] [Abstract][Full Text] [Related]
13. 27-Hydroxycholesterol contributes to cognitive deficits in APP/PS1 transgenic mice through microbiota dysbiosis and intestinal barrier dysfunction.
Wang Y; An Y; Ma W; Yu H; Lu Y; Zhang X; Wang Y; Liu W; Wang T; Xiao R
J Neuroinflammation; 2020 Jun; 17(1):199. PubMed ID: 32593306
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness of anti-inflammatory agents in reducing chemotherapy-induced cognitive impairment in preclinical models - A systematic review.
Haller OJ; Semendric I; George RP; Collins-Praino LE; Whittaker AL
Neurosci Biobehav Rev; 2023 May; 148():105120. PubMed ID: 36906244
[TBL] [Abstract][Full Text] [Related]
15. The microbiota-immune axis as a central mediator of gut-brain communication.
Fung TC
Neurobiol Dis; 2020 Mar; 136():104714. PubMed ID: 31846737
[TBL] [Abstract][Full Text] [Related]
16. The Role of Oxidative Stress in Etiopathogenesis of Chemotherapy Induced Cognitive Impairment (CICI)-"Chemobrain".
Gaman AM; Uzoni A; Popa-Wagner A; Andrei A; Petcu EB
Aging Dis; 2016 May; 7(3):307-17. PubMed ID: 27330845
[TBL] [Abstract][Full Text] [Related]
17. Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment ("chemobrain"), a condition that significantly impairs the quality of life of many cancer survivors.
Ren X; Boriero D; Chaiswing L; Bondada S; St Clair DK; Butterfield DA
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1088-1097. PubMed ID: 30759363
[TBL] [Abstract][Full Text] [Related]
18. The role of the gut microbiota in development, function and disorders of the central nervous system and the enteric nervous system.
Heiss CN; Olofsson LE
J Neuroendocrinol; 2019 May; 31(5):e12684. PubMed ID: 30614568
[TBL] [Abstract][Full Text] [Related]
19. Perioperative considerations in patients with chemotherapy-induced cognitive impairment: a narrative review.
Guran E; Hu J; Wefel JS; Chung C; Cata JP
Br J Anaesth; 2022 Dec; 129(6):909-922. PubMed ID: 36270848
[TBL] [Abstract][Full Text] [Related]
20. Targeting strategies for chemotherapy-induced peripheral neuropathy: does gut microbiota play a role?
Zhong S; Zhou Z; Liang Y; Cheng X; Li Y; Teng W; Zhao M; Liu C; Guan M; Zhao C
Crit Rev Microbiol; 2019 Aug; 45(4):369-393. PubMed ID: 31106639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
